Skip to main content
. 2012 Jun 4;29(9):1736–1746. doi: 10.1089/neu.2011.2162

Table 3.

Summary of Design Features for Spinal Cord Injury Trials in ClinicalTrials.gov

Feature Total count % Pre-2007 count % 2007+ count % % Change p Value
Study type               0.16
 Interventional 225 78.1 94 81.7 124 74.7 31.9  
 Observational 63 21.9 21 18.3 42 25.3 100.0  
Allocation               0.09
 Randomized 147 73.1 57 66.3 91 77.1 59.6  
 Non-randomized 54 26.9 29 33.7 27 22.9 −6.9  
Masking               0.01
 Open label 116 53.5 56 63.6 63 47.4 12.5  
 Double-blind 62 28.6 24 27.3 39 29.3 62.5  
 Single-blind 39 18.0 8 9.1 31 23.3 287.5  
Control               0.34
 Active control 55 36.7 29 40.3 23 34.3 −20.7  
 Placebo control 49 32.7 20 27.8 27 40.3 35.0  
 Uncontrolled 30 20.0 16 22.2 10 14.9 −37.5  
 Dose comparison 13 8.7 5 6.9 7 10.4 40.0  
 Historical control 3 2.0 2 2.8 0 0.0 −100.0  
Design               0.09
 Parallel assignment 96 44.9 33 37.9 64 48.9 93.9  
 Single group assignment 79 36.9 40 46.0 42 32.1 5.0  
 Crossover assignment 36 16.8 12 13.8 24 18.3 100.0  

After study type, all features relate to interventional studies. Counts are numbers of trials. p Values calculated by chi-square test indicate differences between pre-2007 trials and trials from 2007 onward. Categories with counts <10 were not included in p-value calculations. Pre-2007 and post-2007 sums may not match totals since some trials did not report start dates.